Table 6.
Reason for Withdrawal | D-tagatose 2.5g N = 57 n (%) |
D-tagatose 5.0g N = 51 n (%) |
D-tagatose 7.5g N = 53 n (%) |
Total N = 161 n (%) |
---|---|---|---|---|
Subject Request | 3 (5.3%) | 5 (9.8%) | 10 (18.9%) | 18 (11.2%) |
Lost to Follow-up | 3 (5.3%) | 3 (5.9%) | 5 (9.4%) | 11 (6.8%) |
AE/SAE | 5 (8.8%) | 2 (3.9%) | 1 (1.9%) | 8 (5.0%) |
Protocol Deviation | 3 (5.3%) | 2 (3.9%)* | 2 (3.8%) | 7 (4.3%) |
Termination by Sponsor | 2 (3.5%) | 0 (0.0%) | 0 (0.0%) | 2 (1.2%) |
Other | 6 (10.5%)† | 7 (13.7%) | 1 (1.9%) | 14 (8.7%) |
Total Withdrawn | 22 (38.6%) | 19 (37.3%) | 19 (35.8%) | 60 (37.3%) |
N = Randomized subjects; denominator for all percentages
One randomized subject in this dose group had a recorded reason for withdrawal of “screen failure” and was therefore tabulated with those withdrawn for a protocol deviation
One randomized subject in this dose group had no reason for withdrawal specified on the CRF and was therefore tabulated with “Other”